Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Linyuan Peng und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Antigen Presentation, Histocompatibility Antigens Class I, Hippo Signaling Pathway, Signal Transduction. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Pharmaceutical University, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
- Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Cancer Research Center, Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China.
- State Key Laboratory of Natural Medicines, NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Cancer Research Center, Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China. Electronic address: delu@szu.edu.cn.
- State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Electronic address: qmx@cpu.edu.cn.
- State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Electronic address: wangzhongyuan@cpu.edu.cn.
Förderung
- China Pharmaceutical University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Committee
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Peng, L., Zhou, L., Li, H., Zhang, X., Li, S., Wang, K., Yang, M., Ma, X., Zhang, D., Xiang, S., Duan, Y., Wang, T., Sun, C., Wang, C., Lu, D., Qian, M., & Wang, Z. (2024). Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114003
Vancouver
Peng L, Zhou L, Li H, Zhang X, Li S, Wang K, et al. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114003
BibTeX
@article{Peng2024,
author = {Peng, Linyuan and Zhou, Liang and Li, Huan and Zhang, Xin and Li, Su and Wang, Kai and Yang, Mei and Ma, Xiaoyu and Zhang, Danlan and Xiang, Siliang and Duan, Yajun and Wang, Tianzhi and Sun, Chunmeng and Wang, Chen and Lu, Desheng and Qian, Minxian and Wang, Zhongyuan},
title = {Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114003}
}
EUVIMED